Clene Share Price Today
(NASDAQ: CLNN)

Name: Clene Share Price Today (NASDAQ: CLNN) - Clene Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Clene share price is $4.4 & ₹382.66 as on 6 Mar 2025, 2.30 'hrs' IST

$4.4

▲

0.14

(3.29%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Clene share price in Dollar and Rupees. Guide to invest in Clene stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Clene, along with analyst recommendations, forecasts, and comprehensive financials.

Clene share price movements

Today's Low: $4.25
Today's High: $4.53
$4.40
3.41%
Downside
Day's Volatility :6.09%
Upside
2.78%
52 Weeks Low: $3.82
52 Weeks High: $10.40
$4.40
13.23%
Downside
52 Weeks Volatility :63.29%
Upside
57.69%

Clene (CLNN) Returns

Period	Clene Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	2.4%	2.1%	0.0%
6 Months	-32.49%	-4.1%	0.0%
1 Year	-46.08%	2.2%	0.0%
3 Years	-92.53%	11.8%	-11.6%

Clene (CLNN) Key Statistics

in dollars & INR

Previous Close	$4.26
Open	$4.26
Today's High	$4.5256
Today's Low	$4.25
Market Capitalization	$36.1M
Today's Volume	$1.4K
52 Week High	$10.4
52 Week Low	$3.8181
Revenue TTM	$421.0K
EBITDA	$-32.7M
Earnings Per Share (EPS)	$-5.24
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.61%
Return On Equity TTM	-416.92%

How to invest in Clene Stock (CLNN) from India?

It is very easy for Indian residents to invest directly in Clene from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Clene stock in both Indian Rupees (INR) and US Dollars (USD). Search for Clene or CLNN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Clene or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Clene shares which would translate to 0.198 fractional shares of Clene as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Clene, in just a few clicks!

Returns in Clene (CLNN) for Indian investors in Rupees

The Clene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Clene investment value today

Current value as on today

₹60,659

Returns

₹39,341

(-39.34%)

Returns from Clene Stock

₹44,304 (-44.3%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Clene (CLNN)

-10%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Clene Stock from India on INDmoney has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Clene

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Clene(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Clene Stock (CLNN)

What analysts predicted

Upside of 926.52%

Target:

$45.17

Current:

$4.40

Insights on Clene Stock (Ticker Symbol: CLNN)

Price Movement
In the last 3 years, CLNN stock has moved down by -92.7%
Decreasing Revenue
Revenue is down for the last 2 quarters, 91.0K → 87.0K (in $), with an average decrease of 4.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -6.78M → -7.98M (in $), with an average decrease of 17.7% per quarter
CLNN vs K (1 yr)
In the last 1 year, Kellanova has given 54.2% return, outperforming this stock by 97.7%
CLNN vs K (3 yr)
In the last 3 years, Kellanova has given 26.8% return, outperforming this stock by 119.5%
Price to Sales
ForCLNN every $1 of sales, investors are willing to pay $65.5, whereas for Kellanova, the investors are paying $2.2 for every $1 of sales.

Clene Technicals Summary

Sell

Neutral

Buy

Clene is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Clene (CLNN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Clene Inc	-8.39%	-32.49%	-46.08%	-92.53%	-97.64%
Kraft Heinz Company, The	7.94%	-14.25%	-12.36%	-22.84%	29.3%
Mccormick & Company, Incorporated	7.13%	-0.82%	20.57%	-20.85%	14.37%
Hormel Foods Corporation	-1.67%	-10.0%	-15.47%	-44.64%	-33.43%
General Mills, Inc.	3.79%	-17.94%	-6.28%	-9.65%	12.93%
Kellanova	0.75%	2.71%	52.91%	24.9%	31.97%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Clene Inc	4.14	NA	NA	-4.48	-4.17	-0.47	NA	-0.6
Kraft Heinz Company, The	13.86	13.86	0.88	2.77	0.06	0.04	0.05	41.16
Mccormick & Company, Incorporated	29.02	29.02	2.78	3.08	0.15	0.05	0.02	19.74
Hormel Foods Corporation	20.94	20.94	3.05	1.61	0.1	0.05	0.04	14.6
General Mills, Inc.	13.29	13.29	3.45	4.36	0.27	0.07	0.04	16.66
Kellanova	21.29	21.29	1.68	3.92	0.37	0.08	0.03	10.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Clene Inc	Buy	$36.1M	-97.64%	4.14	0.0%
Kraft Heinz Company, The	Buy	$37.4B	29.3%	13.86	10.62%
Mccormick & Company, Incorporated	Hold	$22.7B	14.37%	29.02	11.73%
Hormel Foods Corporation	Hold	$15.9B	-33.43%	20.94	6.35%
General Mills, Inc.	Hold	$33.7B	12.93%	13.29	13.08%
Kellanova	Hold	$28.5B	31.97%	21.29	10.53%

About Clene

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company also develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Organization	Clene
Employees	82
CEO	Mr. Robert Etherington MBA
Industry	Consumer Defensive

Management People of Clene

Name	Title
Mr. Robert Etherington MBA	CEO, President & Director
Mr. Morgan R. Brown CPA, M.B.A.	Chief Financial Officer
Mr. Mark G. Mortenson ESQ.	Chief Science Officer
Mr. Jerry Miraglia J.D.	General Counsel & Corporate Secretary
Mr. Michael T. Hotchkin	Chief Development Officer
Ms. Mary Anne Mcneil	Head of Human Resources
Dr. Benjamin M. Greenberg M.D., M.H.S.	Head of Medical

Important FAQs about investing in CLNN Stock from India :

What is Clene share price today?

Clene share price today stands at $4.40, Open: $4.26 ; Previous Close: $4.26 ; High: $4.53 ; Low: $4.25 ; 52 Week High: $10.40 ; 52 Week Low: $3.82.

The stock opens at $4.26, after a previous close of $4.26. The stock reached a daily high of $4.53 and a low of $4.25, with a 52-week high of $10.40 and a 52-week low of $3.82.

Can Indians buy Clene shares?

Yes, Indians can invest in the Clene (CLNN) from India.

With INDmoney, you can buy Clene at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Clene at zero transaction cost.

How can I buy Clene shares from India?

It is very easy to buy Clene from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Clene (CLNN) be purchased?

Yes, you can buy fractional shares of Clene with INDmoney app.

What are the documents required to start investing in Clene stocks?

To start investing in Clene, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.